NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
Si-bone, Inc. SIBN
9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$200.9M
▲ 20.2% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
$0.00
Payout · FY25
—
ROE · FY25
-11.0%
Net margin · FY25
-9.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 200.9M
Revenue, FY2025 · full 9-year series below
Revenue
Net income
The company lost 9 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
Dividend
The company pays no cash dividend.
Profitability
-11.0%
Return on equity, FY2025
ROE
Operating margin-11.1%
Net margin-9.4%
Return on assets-8.1%
Each USD of equity lost 11 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+22.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+23.6%
+22.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years+34.0%
Change, 10 years—
The share count grew 34% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 238.6M
total assets, end of FY2025
Total assetsUSD 238.6M
EquityUSD 177.5M
CashUSD 42.2M
Gross debtUSD 35.6M
Net debtUSD -6.7M
Current ratio8.55×
The company holds more cash than debt.
History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
·
·
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
·
·
·
·
·
·
·
·
·
Dividend / sh $
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Payout %
·
·
·
·
·
·
·
·
·
ROE %
−11.0
−18.4
−32.4
−52.6
−37.2
−37.6
−50.1
·
·
Shares out B
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
36 of 36
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed